SCHEMBL123864

SCHEMBL123864

C1CCNNCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8047192 1.00 ALDH1A1 (0.50)
SCHEMBL477010 1.00 ALDH1A1 (0.50)
SCHEMBL30019809 1.00 ALDH1A1 (0.50)
SCHEMBL30832504 1.00 ALDH1A1 (0.50)
SCHEMBL1260534 1.00 ALDH1A1 (0.50)
SCHEMBL477057 1.00
SCHEMBL477029 1.00 ALDH1A1 (0.50)
SCHEMBL7770292 1.00 ALDH1A1 (0.50)
SCHEMBL476999 1.00
SCHEMBL28032378 1.00 ALDH1A1 (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3994 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4747245-A1 PHARMACEUTICAL COMPOUNDS Almac Discovery Limited (GB) 2026-05-27 EP claimed
CN-122070278-A Bifunctional protein degradation agent containing aryl substituted heteroaryl and application thereof 标新生物医药科技(上海)有限公司 2026-05-19 CN claimed
US-12630487-B2 Method for introducing deuterated lower alkyl into amine moiety of compound containing secondary amine OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2026-05-19 US claimed
EP-4739682-A1 1,6-NAPHTHRIDINE COMPOUNDS AS SMARCA2 INHIBITORS USEFUL FOR THE TREATMENT OF SMARCA4 DEFICIENT CANCERS Janssen Pharmaceutica NV (BE) 2026-05-13 EP claimed
US-20260070896-A1 HETEROCYCLE DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS UNIV LEUVEN KATH (BE) 2026-03-12 US claimed
EP-4695256-A2 ERBB2 INHIBITORS Cogent Biosciences, Inc. (US) 2026-02-18 EP claimed
EP-4688792-A1 KRAS INHIBITORS Eli Lilly and Company (US) 2026-02-11 EP claimed
EP-4688784-A1 KRAS INHIBITORS Eli Lilly and Company (US) 2026-02-11 EP claimed
US-20260035389-A1 TETRAHYDROPYRIDOPYRIMIDINE PAN-KRAS INHIBITORS MIRATI THERAPEUTICS INC (US) 2026-02-05 US claimed
US-20260015350-A1 AZAQUINAZOLINE PAN-KRAS INHIBITORS MIRATI THERAPEUTICS INC (US) 2026-01-15 US claimed
EP-0213326-B1 2,5-DIMETHYL PYRROLE DERIVATIVES, THEIR PREPARATION AND THEIR USE CASSELLA Aktiengesellschaft (DE) 1991-03-06 EP claimed
US-4952402-A EDIBLE TASTE-MASKED DRUGS; MICROMATRIX ACTIVE MATERIAL COATED WITH NONTOXIC POLYMER; LIQUIDS; TABLETS ELAN CORPORATION, P.L.C. (IE) 1990-08-28 US claimed
US-4904775-A Heteroaroylhydrazide derivatives of monocyclic beta-lactam antibiotics E. R. SQUIBB & SONS, INC. (US) 1990-02-27 US claimed
EP-0342423-A2 Heteroaroylhydrazide derivatives of monocyclic beta-lactam antibiotics E.R. SQUIBB & SONS, INC. (US) 1989-11-23 EP claimed
EP-0336014-A1 Pharmaceutical compositions with controlled release, and a method for their preparation VECTORPHARMA INTERNATIONAL S.p.A. (IT) 1989-10-11 EP claimed
EP-0152598-B1 Cyanomethyl-(2-cyano-ethyl)-(3-hydroxy-propyl)-amine and its use for the production of 1-(3-hydroxy-propyl)-1,4-diazepan and 1,4-bis-[3-(3,4,5-trimethoxy-benzoyloxy)-propyl]-diazepan Degussa Aktiengesellschaft (DE) 1988-04-20 EP claimed
EP-0179583-A1 A system for enhancing the water dissolution rate and solubility of poorly soluble drugs MERCK & CO. INC. (US) 1986-04-30 EP claimed
EP-0072534-B1 BORIC-ACID ESTERS WITH ALKOXYLATED DIAMINES OR TRIAMINES AND THEIR APPLICATION TO HYDRAULIC FLUIDS BASF Aktiengesellschaft (DE) 1985-08-07 EP claimed
EP-0094562-B1 DIAMINE DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND THEIR USE AS FUNGICIDES BASF Aktiengesellschaft (DE) 1984-12-05 EP claimed
EP-0072534-A1 Boric-acid esters with alkoxylated diamines or triamines and their application to hydraulic fluids BASF Aktiengesellschaft (DE) 1983-02-23 EP claimed